article thumbnail

FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology

Bill Of Health

By Aparajita Lath In January, the Federal Trade Commission (FTC) released a new draft rule that would categorically ban non-compete clauses — contractual terms between an employer and an employee that prevent subsequent employment at a competing firm — across the country.

article thumbnail

Range Biotechnologies Raises $5.2M to Advance Proteomics for Precision Health

HIT Consultant

What You Should Know: Range Biotechnologies (Range Bio) announced $5.2M Thus, developing more effective ways to diagnose, treat, and prevent diseases such as cardiovascular disease, cancer, COPD, MS, and more. Proteomics, the study of proteins in the body, has the potential to improve human health in several ways.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

HIT Consultant

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

article thumbnail

clock.bio Raises $5.3M to Decode Human Rejuvenation, Develop Anti-Aging Therapies

HIT Consultant

What You Should Know: – clock.bio , a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M A Vision for Increased Healthspan clock.bio’s mission is to increase human healthspan by developing treatments that prevent and treat age-related diseases.

article thumbnail

Biotech Startup Obatala Sciences Raises $3M for Organ-on-a-Chip for Research

HIT Consultant

These solutions, provided to pharmaceutical companies, government labs, and researchers, are designed to accelerate the study and prevention of diseases in the fields of obesity, diabetes, cancer, and regenerative medicines. Trivia Frazier, Ph.D., Co-Founder, President, & CEO of Obatala Sciences, Inc.

article thumbnail

The Legality of Pandemic Detection and Prevention Technology

Bill Of Health

Despite the promise Ecker’s model holds for preventing the next public health tragedy, there are a number of legal challenges that may obstruct the practical implementation of such a model, as the law strives to balance pressing public health needs with individual civil liberties. A number of U.S. April Xiaoyi Xu (J.D.)

article thumbnail

Petrie-Flom Welcomes 2023-2024 Student Fellows

Bill Of Health

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from Harvard Law School. At the law school, Adithi is interested in examining how emerging biotechnologies in regenerative medicine intersect with patient privacy and other ownership rights.